Teligent OK'd For Fast-Tracked Del. Ch. 11 Disclosure Hearing

Remnants of bankrupt generic pharmaceutical maker Teligent Inc. secured approval Monday for fast-tracked consideration of a liquidating Chapter 11 plan disclosure statement, after reporting that a $3 million settlement with a...

Already a subscriber? Click here to view full article